<DOC>
	<DOCNO>NCT00207103</DOCNO>
	<brief_summary>This Phase I dose escalation study determine safety , pharmacokinetics pharmacodynamics BMS-582664 patient advance metastatic solid tumor .</brief_summary>
	<brief_title>MAD Cancer Patients : Safety BMS-582664 Patients With Advanced Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Diagnosis progressive advance metastatic ( tumor spread ) solid tumor No tumor spread brain Feeling well cancer diagnosis ( i.e . lab work , infection , etc . ) Available tumor tissue sample prior surgery 46 week since prior therapy recover prior therapy Men woman , age 18 Women must pregnant breastfeed Diagnosis advance metastatic ( tumor spread ) colorectal , hepatocellular ( liver ) renal ( kidney ) cancer Measurable disease scan ( least one )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Advanced metastatic solid tumor</keyword>
</DOC>